As of Jun 24
| -1.93 / -3.43%|
The 3 analysts offering 12-month price forecasts for ANI Pharmaceuticals Inc have a median target of 55.00, with a high estimate of 65.00 and a low estimate of 49.00. The median estimate represents a +1.21% increase from the last price of 54.34.
The current consensus among 3 polled investment analysts is to Buy stock in ANI Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.